Journal article 370 views 92 downloads
The effect of particle size on drug bioavailability in various parts of the body
Pharmaceutical Science Advances, Volume: 2, Start page: 100031
Swansea University Author: Zi Hong Mok
-
PDF | Version of Record
© 2023 The Author. This is an open access article under the CC BY license.
Download (2.45MB)
DOI (Published version): 10.1016/j.pscia.2023.100031
Abstract
Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size is one of the challenges as particles need to be delivered from the external environment, into the circulation or interstitial fluid and transiting the cell membranes for cellular internalisation. Small par...
Published in: | Pharmaceutical Science Advances |
---|---|
ISSN: | 2773-2169 |
Published: |
Elsevier BV
2024
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa65724 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2024-03-01T14:57:10Z |
---|---|
last_indexed |
2024-03-01T14:57:10Z |
id |
cronfa65724 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>65724</id><entry>2024-03-01</entry><title>The effect of particle size on drug bioavailability in various parts of the body</title><swanseaauthors><author><sid>4a0b8a58c748d6a2c87a54f263f4d397</sid><ORCID>0000-0002-1231-5048</ORCID><firstname>Zi Hong</firstname><surname>Mok</surname><name>Zi Hong Mok</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-03-01</date><deptcode>PHAR</deptcode><abstract>Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size is one of the challenges as particles need to be delivered from the external environment, into the circulation or interstitial fluid and transiting the cell membranes for cellular internalisation. Small particles are presumably easier to be internalised, yet they are not easy to retain as they are subject to fast clearance. Big particles do not cross biological barriers as easily, but their size distribution is easier to be controlled. Because of the various routes of administration, the size range of these particles will also need to be catered for the anatomical, biological, and dynamic barriers involved. This review hopes to provide an insight into the range of particle size that has been engineered for drug delivery via various routes of administration of the body, such as to cross the epithelium of gastrointestinal tract, lungs, skin, blood-brain barrier, kidney and liver, the eye, nose, and ear, the cancer tumour matrix and into the muscles. While successful drug delivery also depends on the material properties of the delivery systems and the bio/nano interface related properties, this review focuses on the importance of particle size for enhancing bioavailability at the various organs of the body.</abstract><type>Journal Article</type><journal>Pharmaceutical Science Advances</journal><volume>2</volume><journalNumber/><paginationStart>100031</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2773-2169</issnPrint><issnElectronic/><keywords>Particle size; Nanoparticles; Microparticles; Absorption; Internalisation</keywords><publishedDay>1</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-12-01</publishedDate><doi>10.1016/j.pscia.2023.100031</doi><url/><notes/><college>COLLEGE NANME</college><department>Pharmacy</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PHAR</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders>Shandong University</funders><projectreference/><lastEdited>2024-04-25T22:12:23.9974529</lastEdited><Created>2024-03-01T14:55:25.6990894</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Pharmacy</level></path><authors><author><firstname>Zi Hong</firstname><surname>Mok</surname><orcid>0000-0002-1231-5048</orcid><order>1</order></author></authors><documents><document><filename>65724__29623__c973540bebd340d5b56db2cc895425a7.pdf</filename><originalFilename>65724.pdf</originalFilename><uploaded>2024-03-05T08:51:28.9563719</uploaded><type>Output</type><contentLength>2566740</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2023 The Author. This is an open access article under the CC BY license.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
v2 65724 2024-03-01 The effect of particle size on drug bioavailability in various parts of the body 4a0b8a58c748d6a2c87a54f263f4d397 0000-0002-1231-5048 Zi Hong Mok Zi Hong Mok true false 2024-03-01 PHAR Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size is one of the challenges as particles need to be delivered from the external environment, into the circulation or interstitial fluid and transiting the cell membranes for cellular internalisation. Small particles are presumably easier to be internalised, yet they are not easy to retain as they are subject to fast clearance. Big particles do not cross biological barriers as easily, but their size distribution is easier to be controlled. Because of the various routes of administration, the size range of these particles will also need to be catered for the anatomical, biological, and dynamic barriers involved. This review hopes to provide an insight into the range of particle size that has been engineered for drug delivery via various routes of administration of the body, such as to cross the epithelium of gastrointestinal tract, lungs, skin, blood-brain barrier, kidney and liver, the eye, nose, and ear, the cancer tumour matrix and into the muscles. While successful drug delivery also depends on the material properties of the delivery systems and the bio/nano interface related properties, this review focuses on the importance of particle size for enhancing bioavailability at the various organs of the body. Journal Article Pharmaceutical Science Advances 2 100031 Elsevier BV 2773-2169 Particle size; Nanoparticles; Microparticles; Absorption; Internalisation 1 12 2024 2024-12-01 10.1016/j.pscia.2023.100031 COLLEGE NANME Pharmacy COLLEGE CODE PHAR Swansea University Another institution paid the OA fee Shandong University 2024-04-25T22:12:23.9974529 2024-03-01T14:55:25.6990894 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Pharmacy Zi Hong Mok 0000-0002-1231-5048 1 65724__29623__c973540bebd340d5b56db2cc895425a7.pdf 65724.pdf 2024-03-05T08:51:28.9563719 Output 2566740 application/pdf Version of Record true © 2023 The Author. This is an open access article under the CC BY license. true eng https://creativecommons.org/licenses/by/4.0/ |
title |
The effect of particle size on drug bioavailability in various parts of the body |
spellingShingle |
The effect of particle size on drug bioavailability in various parts of the body Zi Hong Mok |
title_short |
The effect of particle size on drug bioavailability in various parts of the body |
title_full |
The effect of particle size on drug bioavailability in various parts of the body |
title_fullStr |
The effect of particle size on drug bioavailability in various parts of the body |
title_full_unstemmed |
The effect of particle size on drug bioavailability in various parts of the body |
title_sort |
The effect of particle size on drug bioavailability in various parts of the body |
author_id_str_mv |
4a0b8a58c748d6a2c87a54f263f4d397 |
author_id_fullname_str_mv |
4a0b8a58c748d6a2c87a54f263f4d397_***_Zi Hong Mok |
author |
Zi Hong Mok |
author2 |
Zi Hong Mok |
format |
Journal article |
container_title |
Pharmaceutical Science Advances |
container_volume |
2 |
container_start_page |
100031 |
publishDate |
2024 |
institution |
Swansea University |
issn |
2773-2169 |
doi_str_mv |
10.1016/j.pscia.2023.100031 |
publisher |
Elsevier BV |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Pharmacy{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Pharmacy |
document_store_str |
1 |
active_str |
0 |
description |
Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size is one of the challenges as particles need to be delivered from the external environment, into the circulation or interstitial fluid and transiting the cell membranes for cellular internalisation. Small particles are presumably easier to be internalised, yet they are not easy to retain as they are subject to fast clearance. Big particles do not cross biological barriers as easily, but their size distribution is easier to be controlled. Because of the various routes of administration, the size range of these particles will also need to be catered for the anatomical, biological, and dynamic barriers involved. This review hopes to provide an insight into the range of particle size that has been engineered for drug delivery via various routes of administration of the body, such as to cross the epithelium of gastrointestinal tract, lungs, skin, blood-brain barrier, kidney and liver, the eye, nose, and ear, the cancer tumour matrix and into the muscles. While successful drug delivery also depends on the material properties of the delivery systems and the bio/nano interface related properties, this review focuses on the importance of particle size for enhancing bioavailability at the various organs of the body. |
published_date |
2024-12-01T22:12:24Z |
_version_ |
1797342672521789440 |
score |
11.037603 |